HB 174 Utah House · 2026 General Session

Sex Characteristic Change Treatment Amendments

HB 174 prohibits health care providers in Utah from administering cross-sex hormones or puberty blockers to minors after January 28, 2027, unless the minor was diagnosed with gender dysphoria before January 28, 2023. The bill amends Utah Code Section 58-1-603.1 to establish this ban, directly affecting minors seeking these treatments who do not meet the pre-2023 diagnosis requirement. It repeals a prior requirement for medical evidence reviews (Section 26B-1-239) and takes effect on May 6, 2026. The law applies to all minors under Utah's definition, with violations classified as unprofessional conduct for providers.
Bill status signed all 5 stages cleared
Introduction
Jan 2026
Committee Review
Feb 2026
House Passage
Mar 2026
Senate Passage
Feb 2026
Signed into Law
Mar 2026
Introduced Jan 20, 2026 Signed Mar 18, 2026
Maddy AI version diff · 7 comparisons

What changed between versions

Substitute #1 Substitute #2 · 5 edits
MODERATE
The bill was amended to clarify the effective date and add specific conditions for minors receiving hormonal transgender treatment. The most significant change is the addition of a new eligibility criterion in Subsection (3), which now prohibits treatment for minors who would be younger than 16 years old as of the bill's effective date or who have not yet received cross-sex hormones by that date. The bill also added a new definition for 'Cross-sex hormone treatment' and modified the definition of 'Hormonal transgender treatment' to explicitly reference the new term. Additionally, the effective date section was expanded to include provisions for special approval scenarios, and a revisor instruction was added to ensure the final code reflects the actual effective date.
Scope change
The bill's scope was narrowed for younger minors by adding an age threshold (under 16) and a prior treatment history requirement as conditions for the prohibition on providing hormonal transgender treatment.
ELIGIBILITY

Added a new condition prohibiting treatment for minors who would be under 16 years old as of the effective date or who have not received cross-sex hormones by that date.

DEFINITION

Added a specific definition for 'Cross-sex hormone treatment' detailing the administration of testosterone to females and estrogen to males.

Modified the definition of 'Hormonal transgender treatment' to reference the newly defined 'Cross-sex hormone treatment' term.

TIMELINE

Expanded the effective date section to include provisions for special approval scenarios, such as gubernatorial approval or veto override.

TECHNICAL

Added a revisor instruction to replace the placeholder 'effective date of this bill' with the actual date in the final code.

Floor votes · Senate Feb 27, 2026 · House Feb 5, 2026

How they voted

206
Passed · 3 other
Total votes 29
Feb 27, 2026
D Democratic6
6 Nay
100% Nay
N Forward1
1
0% Nay
R Republican22
20 Yea 2
90% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
63
Key actions
10
Committee
4
Amendments
6
Mar 18, 2026
Signed into law
Governor Signed
executive
Mar 3, 2026
Lower · Passed
House/ signed by Speaker/ sent for enrolling
lower
Mar 3, 2026
Lower · Passed
Senate/ signed by President/ returned to House
lower
Mar 2, 2026
Upper · Passed
House/ concurs with Senate amendment
upper
Feb 27, 2026
Introduced
Senate/ to House with amendments
lower
Feb 27, 2026
Lower · Passed
Senate/ passed 3rd reading
lower
Feb 19, 2026
Upper · Passed
Senate/ comm rpt/ amended [Senate Judiciary, Law Enforcement, and Criminal Justice Committee]
upper
Feb 19, 2026
Upper · Passed
Senate Comm - Favorable Recommendation [Senate Judiciary, Law Enforcement, and Criminal Justice Committee]
upper
Feb 19, 2026
Introduced
Senate Comm - Amendment Recommendation [Senate Judiciary, Law Enforcement, and Criminal Justice Committee]
upper
Feb 9, 2026
Committee
Senate/ to standing committee [Senate Judiciary, Law Enforcement, and Criminal Justice Committee]
upper
Feb 6, 2026
Introduced
Senate/ 1st reading (Introduced)
upper
Feb 5, 2026
Upper · Passed
House/ passed 3rd reading
upper
Jan 28, 2026
Lower · Passed
House/ comm rpt/ amended [House Health and Human Services Committee]
lower
Jan 27, 2026
Lower · Passed
House Comm - Favorable Recommendation [House Health and Human Services Committee]
lower
Jan 27, 2026
Introduced
House Comm - Amendment Recommendation [House Health and Human Services Committee]
lower
Jan 26, 2026
Committee
House/ to standing committee [House Health and Human Services Committee]
lower
Jan 20, 2026
Introduced
House/ 1st reading (Introduced)
lower
1 primary · 1 co-sponsor

Sponsors